"But Kennedy's summertime purge of the committee - and the lack of a full-time political leader at the agency - has many in the scientific community convinced that the new appointees will rubber-stamp more limits on who can get routine shots. What they're saying: "ACIP has quite literally been the north star of America's approach to vaccination for decades,"Jason Schwartz, a vaccine policy expert and associate professor at the Yale School of Public Health, told Axios. "That's why it was so often the focus of criticism by critics of vaccines, and I think that's why we're seeing such attention on the part of the administration.""
"Inside the room: The ACIP agenda calls for discussions over two days on the hepatitis B vaccine, the MMRV vaccine and COVID boosters, as well as the safety review of COVID vaccines already delivered. The Washington Post reported Trump administration officials will present data from a federal database of adverse events and side effects linking COVID vaccines to the deaths of 25 children, even though the database isn't designed to show causality. Other topics on the agenda include reports of seizures following MMRV vaccine and doses of hepatitis B vaccine given at birth."
Kennedy's summertime purge of the committee and the absence of a full-time political leader at the agency have led many in the scientific community to fear that new appointees will approve stricter limits on routine vaccinations. ACIP long served as the primary advisory body guiding vaccination recommendations. Democratic governors issued state immunization guidelines that may remove prescription requirements for the 2025–2026 COVID booster. Health insurers pledged to continue covering ACIP-recommended immunizations, including updated COVID and flu shots, at no cost through next year. ACIP's upcoming agenda includes hepatitis B, MMRV, COVID boosters, safety reviews, and a shift away from liaison input from some healthcare organizations.
Read at Axios
Unable to calculate read time
Collection
[
|
...
]